Glenmede Trust Co. NA Has $27.25 Million Stock Holdings in CME Group Inc. $CME

Glenmede Trust Co. NA trimmed its position in shares of CME Group Inc. (NASDAQ:CME) by 5.2% in the 1st quarter, Holdings Channel.com reports. The fund owned 92,262 shares of the financial services provider’s stock after selling 5,057 shares during the quarter. Glenmede Trust Co. NA’s holdings in CME Group were worth $27,250,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. Whipplewood Advisors LLC grew its stake in CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares in the last quarter. Asset Dedication LLC raised its stake in shares of CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares in the last quarter. FNY Investment Advisers LLC purchased a new stake in shares of CME Group during the 4th quarter worth about $27,000. Elkhorn Partners Limited Partnership acquired a new stake in shares of CME Group during the 4th quarter valued at about $27,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in shares of CME Group during the 4th quarter valued at about $28,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME opened at $267.79 on Friday. The company has a market capitalization of $96.29 billion, a PE ratio of 22.71, a price-to-earnings-growth ratio of 3.12 and a beta of 0.25. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The company’s fifty day moving average price is $250.89 and its 200 day moving average price is $281.05.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The company had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business’s quarterly revenue was up .8% compared to the same quarter last year. During the same period in the prior year, the company earned $2.96 earnings per share. As a group, analysts expect that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Tuesday, June 9th were paid a dividend of $1.30 per share. The ex-dividend date was Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio is presently 44.11%.

Insider Buying and Selling at CME Group

In other news, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares in the company, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently commented on CME shares. Piper Sandler lowered their price target on CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a research note on Wednesday, July 15th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Keefe, Bruyette & Woods raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price for the company in a research report on Thursday, June 18th. Morgan Stanley boosted their target price on shares of CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a research report on Thursday, July 23rd. Finally, Erste Group Bank lowered shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, June 5th. Eleven investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $291.81.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.